Innovotech Inc Cash Flow Conversion Efficiency
Innovotech Inc cash flow conversion efficiency. Based on the latest financial reports, Innovotech Inc (IOT) has a cash flow conversion efficiency ratio of -0.247x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-640.67K ≈ $-463.45K USD) by net assets (CA$2.59 Million ≈ $1.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Innovotech Inc (2003–2025)
Cash flow conversion efficiency of Innovotech Inc from 2003 to 2025. This chart illustrates how Innovotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Innovotech Inc stock price today for real-time trading data and today's change.
Innovotech Inc Cash Flow Conversion Ratio Explained
Innovotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Innovotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innovotech Inc ranked by their cash flow conversion efficiency. Also see Innovotech Inc (IOT) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kanger International Bhd
KLSE:0170
|
-0.041x |
|
Playfair Mining Ltd.
V:PLY
|
-0.099x |
|
Galilee Energy Ltd
AU:GLL
|
24.798x |
|
Galore Resources Inc
V:GRI
|
-0.017x |
|
Bluechiip Ltd
AU:BCT
|
-3.489x |
|
Golden Goliath Resources Ltd.
V:GNG
|
-0.603x |
|
BCM Alliance Bhd
KLSE:0187
|
0.048x |
|
ZHENRO PROP.GRP DL-00001
F:1ZZ
|
N/A |
Annual Cash Flow Conversion Efficiency for Innovotech Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Innovotech Inc from 2003 to 2025. Review IOT free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$3.65 Million ≈ $2.64 Million |
CA$-62.35K ≈ $-45.11K |
-0.017x | +45.09% |
| 2024-12-31 | CA$2.62 Million ≈ $1.90 Million |
CA$-81.64K ≈ $-59.06K |
-0.031x | +86.37% |
| 2023-12-31 | CA$998.60K ≈ $722.37K |
CA$-228.08K ≈ $-164.99K |
-0.228x | -215.91% |
| 2022-12-31 | CA$1.06 Million ≈ $764.99K |
CA$208.39K ≈ $150.75K |
0.197x | +826.07% |
| 2021-12-31 | CA$1.18 Million ≈ $851.37K |
CA$25.04K ≈ $18.12K |
0.021x | -92.17% |
| 2020-12-31 | CA$644.98K ≈ $466.57K |
CA$175.24K ≈ $126.76K |
0.272x | -65.07% |
| 2019-12-31 | CA$98.09K ≈ $70.95K |
CA$76.30K ≈ $55.19K |
0.778x | +125.90% |
| 2018-12-31 | CA$93.47K ≈ $67.61K |
CA$-280.75K ≈ $-203.09K |
-3.004x | -243.54% |
| 2017-12-31 | CA$181.51K ≈ $131.30K |
CA$-158.69K ≈ $-114.80K |
-0.874x | -45878.85% |
| 2016-12-31 | CA$-1.22 Million ≈ $-881.43K |
CA$2.32K ≈ $1.68K |
-0.002x | +95.34% |
| 2015-12-31 | CA$-1.00 Million ≈ $-725.51K |
CA$40.90K ≈ $29.58K |
-0.041x | -135.58% |
| 2014-12-31 | CA$-765.66K ≈ $-553.87K |
CA$-87.75K ≈ $-63.48K |
0.115x | -88.37% |
| 2013-12-31 | CA$-569.33K ≈ $-411.85K |
CA$-560.96K ≈ $-405.79K |
0.985x | +6432.59% |
| 2003-12-31 | CA$836.94K ≈ $605.43K |
CA$-13.02K ≈ $-9.42K |
-0.016x | -171.08% |
| 2003-09-30 | CA$841.40K ≈ $608.65K |
CA$18.42K ≈ $13.32K |
0.022x | -- |
About Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more